Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1978 3
1980 2
1981 2
1982 1
1983 3
1984 3
1985 4
1986 7
1987 3
1988 4
1989 8
1990 13
1991 4
1992 8
1993 5
1994 7
1995 7
1996 2
1997 8
1998 13
1999 11
2000 13
2001 13
2002 10
2003 4
2004 16
2005 11
2006 13
2007 14
2008 19
2009 29
2010 21
2011 24
2012 23
2013 22
2014 25
2015 10
2016 11
2017 11
2018 12
2019 7
2020 2
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

398 results
Results by year
Filters applied: . Clear all
Page 1
The urinary microbiome associated with bladder cancer.
Bučević Popović V, Šitum M, Chow CT, Chan LS, Roje B, Terzić J. Bučević Popović V, et al. Among authors: chan ls. Sci Rep. 2018 Aug 14;8(1):12157. doi: 10.1038/s41598-018-29054-w. Sci Rep. 2018. PMID: 30108246 Free PMC article.
In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC, Xu J, Bian X, Wu JL, Kang W, Qian Y, Li W, Chen H, Gou H, Liu D, Luk STY, Zhou Q, Ji F, Chan LS, Shirasawa S, Sung JJ, Yu J. Wong CC, et al. Among authors: chan ls. Gastroenterology. 2020 Dec;159(6):2163-2180.e6. doi: 10.1053/j.gastro.2020.08.016. Epub 2020 Aug 16. Gastroenterology. 2020. PMID: 32814111 Free article.
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial.
Zhu AX, Park JO, Ryoo BY, Yen CJ, Poon R, Pastorelli D, Blanc JF, Chung HC, Baron AD, Pfiffer TE, Okusaka T, Kubackova K, Trojan J, Sastre J, Chau I, Chang SC, Abada PB, Yang L, Schwartz JD, Kudo M; REACH Trial Investigators. Zhu AX, et al. Lancet Oncol. 2015 Jul;16(7):859-70. doi: 10.1016/S1470-2045(15)00050-9. Epub 2015 Jun 18. Lancet Oncol. 2015. PMID: 26095784 Clinical Trial.
398 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page